FEDERICO
PULIDO ORTEGA
Profesor asociado
Universidad Europea de Madrid
Madrid, EspañaPublications in collaboration with researchers from Universidad Europea de Madrid (25)
2024
2021
-
COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study
HIV Medicine, Vol. 22, Núm. 9, pp. 867-876
-
Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study
The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 3, pp. 738-742
-
Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study
BMC Infectious Diseases, Vol. 21, Núm. 1
2020
-
Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)
EBioMedicine, Vol. 55
-
Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study
AIDS Research and Therapy, Vol. 17, Núm. 1
-
How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain
HIV Medicine, Vol. 21, Núm. 2, pp. 128-134
2019
-
Predictive factors of hepatitis C virus eradication after interferon-free therapy in HIV coinfection
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 4, pp. 725-734
2016
-
Toward a comprehensive care of HIV patients: finding a strategy to detect depression in a Spanish HIV cohort
AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 28, Núm. 7, pp. 834-841
2014
-
A prospective cohort study of neurocognitive function in aviremic HIV-infected patients treated with 1 or 3 antiretrovirals
Clinical Infectious Diseases, Vol. 59, Núm. 11, pp. 1627-1634
2013
-
Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization?
AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 25, Núm. 8, pp. 980-989
-
Neurocognitive Impairment in Patients Treated with Protease Inhibitor Monotherapy or Triple Drug Antiretroviral Therapy
PLoS ONE, Vol. 8, Núm. 7
-
Should we look for Strongyloides stercoralis in foreign-born HIV-infected persons?
Journal of Immigrant and Minority Health, Vol. 15, Núm. 4, pp. 796-802
2012
-
Características clínico-epidemiológicas de los pacientes inmigrantes con infección por el VIH: estudio de 371 casos
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 8, pp. 441-451
-
Chagas disease screening among HIV-positive Latin American immigrants: An emerging problem
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 31, Núm. 8, pp. 1991-1997
2010
-
Boosted protease inhibitor monotherapy. What have we learnt after seven years of research?
AIDS Reviews, Vol. 12, Núm. 3, pp. 127-134
2009
-
Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression
Antiviral Therapy, Vol. 14, Núm. 2, pp. 195-201
2008
-
Interpretación y consideraciones metodológicas y estadísticas en los estudios de rescate
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. SUPPL. 12, pp. 47-52
-
Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression
Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 6, pp. 1359-1361